Killer cell immunoglobulin-like receptor 3DL1 polymorphism defines distinct hierarchies of HLA class I recognition

Author:

Saunders Philippa M.1,Pymm Phillip234,Pietra Gabriella56,Hughes Victoria A.234,Hitchen Corinne2,O’Connor Geraldine M.1,Loiacono Fabrizio7,Widjaja Jacqueline1,Price David A.89,Falco Michela7,Mingari Maria Cristina56,Moretta Lorenzo10,McVicar Daniel W.11,Rossjohn Jamie2348,Brooks Andrew G.1,Vivian Julian P.234

Affiliation:

1. Department of Microbiology and Immunology, Peter Doherty Institute for Infection and Immunity, The University of Melbourne, Parkville, Victoria 3010, Australia

2. Infection and Immunity Program, Biomedicine Discovery Institute, Monash University, Clayton, Victoria 3800, Australia

3. Department of Biochemistry and Molecular Biology, Monash University, Clayton, Victoria 3800, Australia

4. Australian Research Council Centre of Excellence in Advanced Molecular Imaging, Monash University, Clayton, Victoria 3800, Australia

5. Department of Experimental Medicine, University of Genova, 16132 Genoa, Italy

6. IRCCS AOU San Martino-IST (National Institute for Cancer Research), 16132 Genoa, Italy

7. IRCCS Istituto Giannina Gaslini, 16148 Genoa, Italy

8. Institute of Infection and Immunity, Cardiff University School of Medicine, Heath Park, Cardiff CF14 4XN, Wales, UK

9. Human Immunology Section, Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892

10. IRCCS Ospedale Pediatrico Bambino Gesù, 00146 Rome, Italy

11. Cancer and Inflammation Program, National Cancer Institute–Frederick, Frederick, MD 21701

Abstract

Natural killer (NK) cells play a key role in immunity, but how HLA class I (HLA-I) and killer cell immunoglobulin-like receptor 3DL1 (KIR3DL1) polymorphism impacts disease outcome remains unclear. KIR3DL1 (*001/*005/*015) tetramers were screened for reactivity against a panel of HLA-I molecules. This revealed different and distinct hierarchies of specificity for each KIR3DL1 allotype, with KIR3DL1*005 recognizing the widest array of HLA-I ligands. These differences were further reflected in functional studies using NK clones expressing these specific KIR3DL1 allotypes. Unexpectedly, the Ile/Thr80 dimorphism in the Bw4-motif did not categorically define strong/weak KIR3DL1 recognition. Although the KIR3DL1*001, *005, and *015 polymorphisms are remote from the KIR3DL1–HLA-I interface, the structures of these three KIR3DL1–HLA-I complexes showed that the broader HLA-I specificity of KIR3DL1*005 correlated with an altered KIR3DL1*005 interdomain positioning and increased mobility within its ligand-binding site. Collectively, we provide a generic framework for understanding the impact of KIR3DL1 polymorphism on the recognition of HLA-I allomorphs.

Funder

National Health and Medical Research Council

Worldwide Cancer Research

National Cancer Institute

Wellcome Trust

NHMRC

Australian Research Council

Associazione Italiana per la Ricerca sul Cancro

Publisher

Rockefeller University Press

Subject

Immunology,Immunology and Allergy

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3